Individualized multi-omic pathway deviation scores using multiple factor analysis - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles Biostatistics Year : 2020

Individualized multi-omic pathway deviation scores using multiple factor analysis

Abstract

Malignant progression of normal tissue is typically driven by complex networks of somatic changes, including genetic mutations, copy number aberrations, epigenetic changes, and transcriptional reprogramming. To delineate aberrant multi-omic tumor features that correlate with clinical outcomes, we present a novel pathway-centric tool based on the multiple factor analysis framework called padma. Using a multi-omic consensus representation, padma quantifies and characterizes individualized pathway-specific multi-omic deviations and their underlying drivers, with respect to the sampled population. We demonstrate the utility of padma to correlate patient outcomes with complex genetic, epigenetic, and transcriptomic perturbations in clinically actionable pathways in breast and lung cancer.

Domains

Animal genetics

Dates and versions

hal-02968360 , version 1 (15-10-2020)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Andrea Rau, Regina Manansala, Michael Flister, Hallgeir Rui, Florence Jaffrezic, et al.. Individualized multi-omic pathway deviation scores using multiple factor analysis. Biostatistics, 2020, 23 (2), pp.362-379. ⟨10.1093/biostatistics/kxaa029⟩. ⟨hal-02968360⟩
67 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More